The 3D printed drugs market is emerging as one of the most transformative segments in pharmaceutical manufacturing. According to Business Market Insights, the market was valued at USD 37 Billion in 2025 and is expected to reach USD 84.14 Billion by 2033, registering a strong CAGR of 10.82% during the forecast period from 2026 to 2033.   3D printed drugs are manufactured using additive...